Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Sarepta Therapeutics (SRPT)

Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Sarepta Therapeutics Provides Statement on ELEVIDYS

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today issued the following statement: Shortly after 2:30 p.m. ET today, Sarepta received an...

SRPT : 14.07 (-35.94%)
SRPT Shareholders Have the Right to Lead the Sarepta Therapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group Before the Final Deadline - SRPT

LOS ANGELES , July 18, 2025 /PRNewswire/ -- The DJS Law Group  reminds investors of a class action lawsuit against Sarepta Therapeutics, Inc. ("Sarepta" or "the Company") (NASDAQ:...

SRPT : 14.07 (-35.94%)
SRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES , July 18, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Sarepta...

SRPT : 14.07 (-35.94%)
Stocks Finish Slightly Lower on Mixed Earnings Results

The S&P 500 Index ($SPX ) (SPY ) Friday closed down -0.01%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.32%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.05%. September E-mini...

CVS : 61.96 (-2.12%)
SRPT : 14.07 (-35.94%)
ALV : 112.08 (-4.02%)
IVZ : 19.92 (+15.28%)
$IUXX : 23,065.47 (-0.05%)
ELV : 277.09 (-8.38%)
UNH : 282.65 (-1.88%)
ZNU25 : 110-250s (+0.24%)
ABT : 123.67 (+2.62%)
ESU25 : 6,334.75s (-0.09%)
TLN : 328.63 (+24.48%)
$DOWI : 44,342.19 (-0.32%)
SRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Sarepta Therapeutics, Inc. (“Sarepta” or “the Company”) (NASDAQ:...

SRPT : 14.07 (-35.94%)
Investors Urged to Contact Levi & Korsinsky for Information Before August 25, 2025 - Sarepta Therapeutics, Inc. (SRPT)

New York, New York--(Newsfile Corp. - July 18, 2025) - If you suffered a loss on your Sarepta Therapeutics, Inc. (NASDAQ: SRPT) investment and want to learn about a potential recovery under the federal...

SRPT : 14.07 (-35.94%)
Stocks Pressured by Weakness in Netflix and Health Insurers

The S&P 500 Index ($SPX ) (SPY ) today down -0.08%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.44%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.15%. September E-mini S&P futures...

CVS : 61.96 (-2.12%)
SRPT : 14.07 (-35.94%)
ALV : 112.08 (-4.02%)
IVZ : 19.92 (+15.28%)
$IUXX : 23,065.47 (-0.05%)
ELV : 277.09 (-8.38%)
ZNU25 : 110-250s (+0.24%)
ABT : 123.67 (+2.62%)
ESU25 : 6,334.75s (-0.09%)
TLN : 328.63 (+24.48%)
$DOWI : 44,342.19 (-0.32%)
SPY : 627.58 (-0.07%)
Stocks See Support from Dovish Fed Official Comment

The S&P 500 Index ($SPX ) (SPY ) today is up +0.18%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.18%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.17%. September E-mini S&P futures...

NFLX : 1,209.24 (-5.10%)
IBKR : 64.05 (+7.77%)
SRPT : 14.07 (-35.94%)
$SPX : 6,296.79 (-0.01%)
SYM : 54.54 (+0.66%)
ALV : 112.08 (-4.02%)
MMM : 153.23 (-3.65%)
$IUXX : 23,065.47 (-0.05%)
NQU25 : 23,224.25s (-0.12%)
ELV : 277.09 (-8.38%)
QQQ : 561.26 (-0.10%)
ZNU25 : 110-250s (+0.24%)
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Sarepta Therapeutics, Inc.(SRPT) Shareholders

NEW YORK , July 18, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Sarepta Therapeutics, Inc. ("Sarepta" or the "Company") (NASDAQ: SRPT) of a class action securities...

SRPT : 14.07 (-35.94%)
SRPT INVESTOR DEADLINE: Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

SAN DIEGO , July 18, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Sarepta Therapeutics,...

SRPT : 14.07 (-35.94%)

Barchart Exclusives

The Saturday Spread: Using Science to Pinpoint Empirically Enticing Trades in WMT, OKTA and RCAT
If you’re going to extract alpha from the market, you’ll need an objective framework to benchmark and quantify your performance. This article will show you how. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar